Healthpeak Properties (NYSE:DOC) Issues FY 2026 Earnings Guidance

Posted by Francis Steltz on Nov 3rd, 2026

Healthpeak Properties (NYSE:DOC – Get Free Report) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.760-1.780 for the period, compared to the consensus estimate of 1.770.

Healthpeak Properties Stock Up 0.7%

NYSE:DOC traded up $0.14 during mid-day trading on Tuesday, hitting $19.62. The stock had a trading volume of 996,867 shares, compared to its average volume of 7,639,723. The company has a market capitalization of $13.53 billion, a PE ratio of 56.12, a PEG ratio of 2.29 and a beta of 1.01. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock has a 50-day simple moving average of $19.86 and a two-hundred day simple moving average of $19.15. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95.

Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.41). Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $820.89 million during the quarter, compared to analysts’ expectations of $739.18 million. During the same quarter in the prior year, the firm posted $0.46 EPS. Healthpeak Properties’s quarterly revenue was up 16.3% compared to the same quarter last year. On average, equities research analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be issued a $0.1017 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date is Friday, December 18th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on DOC. Weiss Ratings cut Healthpeak Properties from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Citigroup increased their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Mizuho increased their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. Jefferies Financial Group initiated coverage on Healthpeak Properties in a research note on Tuesday, September 15th. They issued a “hold” rating and a $21.00 price target on the stock. Finally, Barclays dropped their price target on Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus target price of $21.60.

Check Out Our Latest Research Report on DOC

Healthpeak Properties News Roundup

Here are the key news stories impacting Healthpeak Properties this week:

Positive Sentiment: Healthpeak reported third-quarter adjusted FFO of $0.44 per share, ahead of the $0.43 consensus estimate, while revenue rose 16.3% year over year to $820.9 million. Healthpeak Q3 FFO and Revenues Surpass Estimates
Positive Sentiment: The healthcare REIT raised its full-year 2026 guidance to $1.76-$1.78 per share, broadly in line with the $1.77 analyst consensus. The company also highlighted 846,000 square feet of outpatient medical lease executions during the quarter, supporting expectations for continued operational growth. Healthpeak Reports Third Quarter Results and Increases Guidance
Neutral Sentiment: Management’s guidance increase is constructive, but the midpoint is essentially unchanged from expectations, limiting the potential for a major earnings-driven revaluation. Healthpeak Expects 2026 AFFO Range
Negative Sentiment: Reported GAAP EPS was only $0.02, well below the $0.43 consensus estimate. Adjusted FFO also declined from $0.46 per share a year earlier, indicating pressure despite revenue growth. Healthpeak Q3 Revenue Earnings Flash
Negative Sentiment: Third-quarter revenue of $820.9 million was below the $889 million FactSet estimate, creating a near-term concern about the pace and quality of growth. The stock also underperformed some real estate competitors despite trading higher. Healthpeak Stock Underperforms Competitors

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.